Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Halogenated Arylamine. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN101811973A enables high-selectivity solvent-free hydrogenation for halogenated arylamines. Discover cost reduction and supply chain advantages for pharmaceutical intermediates manufacturing.
Novel metal-free synthesis of ortho-haloarylamines using dihalo sulfoxide. High regioselectivity, mild conditions, ideal for reliable pharmaceutical intermediate supply chains.
Patent CN112047879B details a novel copper-catalyzed method for selective halogenation, offering cost-effective and scalable solutions for API intermediate manufacturing.
Discover how copper-catalyzed halogenation reduces costs and improves yield for pharmaceutical intermediates. Scale with NINGBO INNO PHARMCHEM's CDMO expertise.